Disclosed is a method for inducing/maintaining remission of an immune disease, which can reduce serious adverse side effects and stress in a patient. After the induction of remission of an immune disease with a biological substance or a nucleic acid synthesis inhibitor, a sphingosine-1-phosphate receptor agonist is used.